Form 8-K - Current report:
SEC Accession No. 0001104659-25-056665
Filing Date
2025-06-05
Accepted
2025-06-05 07:10:35
Documents
51
Period of Report
2025-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517185d1_8k.htm   iXBRL 8-K 24931
2 EXHIBIT 99.1 tm2517185d1_ex99-1.htm EX-99.1 18914
3 EXHIBIT 99.2 tm2517185d1_ex99-2.htm EX-99.2 58707
7 GRAPHIC tm2517185d1_ex99-1img001.jpg GRAPHIC 5223
8 GRAPHIC tm2517185d1_ex99-2img001.jpg GRAPHIC 61931
9 GRAPHIC tm2517185d1_ex99-2img002.jpg GRAPHIC 326868
10 GRAPHIC tm2517185d1_ex99-2img003.jpg GRAPHIC 141524
11 GRAPHIC tm2517185d1_ex99-2img004.jpg GRAPHIC 179447
12 GRAPHIC tm2517185d1_ex99-2img005.jpg GRAPHIC 145879
13 GRAPHIC tm2517185d1_ex99-2img006.jpg GRAPHIC 142699
14 GRAPHIC tm2517185d1_ex99-2img007.jpg GRAPHIC 164558
15 GRAPHIC tm2517185d1_ex99-2img008.jpg GRAPHIC 188515
16 GRAPHIC tm2517185d1_ex99-2img009.jpg GRAPHIC 136004
17 GRAPHIC tm2517185d1_ex99-2img010.jpg GRAPHIC 110213
18 GRAPHIC tm2517185d1_ex99-2img011.jpg GRAPHIC 183090
19 GRAPHIC tm2517185d1_ex99-2img012.jpg GRAPHIC 123465
20 GRAPHIC tm2517185d1_ex99-2img013.jpg GRAPHIC 166175
21 GRAPHIC tm2517185d1_ex99-2img014.jpg GRAPHIC 136407
22 GRAPHIC tm2517185d1_ex99-2img015.jpg GRAPHIC 139194
23 GRAPHIC tm2517185d1_ex99-2img016.jpg GRAPHIC 85096
24 GRAPHIC tm2517185d1_ex99-2img017.jpg GRAPHIC 179866
25 GRAPHIC tm2517185d1_ex99-2img018.jpg GRAPHIC 117397
26 GRAPHIC tm2517185d1_ex99-2img019.jpg GRAPHIC 143980
27 GRAPHIC tm2517185d1_ex99-2img020.jpg GRAPHIC 145758
28 GRAPHIC tm2517185d1_ex99-2img021.jpg GRAPHIC 104085
29 GRAPHIC tm2517185d1_ex99-2img022.jpg GRAPHIC 105757
30 GRAPHIC tm2517185d1_ex99-2img023.jpg GRAPHIC 170821
31 GRAPHIC tm2517185d1_ex99-2img024.jpg GRAPHIC 45711
32 GRAPHIC tm2517185d1_ex99-2img025.jpg GRAPHIC 184378
33 GRAPHIC tm2517185d1_ex99-2img026.jpg GRAPHIC 53819
34 GRAPHIC tm2517185d1_ex99-2img027.jpg GRAPHIC 175945
35 GRAPHIC tm2517185d1_ex99-2img028.jpg GRAPHIC 42182
36 GRAPHIC tm2517185d1_ex99-2img029.jpg GRAPHIC 153025
37 GRAPHIC tm2517185d1_ex99-2img030.jpg GRAPHIC 151135
38 GRAPHIC tm2517185d1_ex99-2img031.jpg GRAPHIC 141183
39 GRAPHIC tm2517185d1_ex99-2img032.jpg GRAPHIC 134191
40 GRAPHIC tm2517185d1_ex99-2img033.jpg GRAPHIC 37399
41 GRAPHIC tm2517185d1_ex99-2img034.jpg GRAPHIC 138597
42 GRAPHIC tm2517185d1_ex99-2img035.jpg GRAPHIC 144012
43 GRAPHIC tm2517185d1_ex99-2img036.jpg GRAPHIC 61931
  Complete submission text file 0001104659-25-056665.txt   6999920

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA knsa-20250605.xsd EX-101.SCH 3011
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20250605_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20250605_pre.xml EX-101.PRE 22356
53 EXTRACTED XBRL INSTANCE DOCUMENT tm2517185d1_8k_htm.xml XML 3595
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 251025017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)